热门资讯> 正文
Xeris Bizerma首席执行官Paul Edick将退休
2024-07-08 19:31
- Xeris Biopharma (NASDAQ:XERS) said Paul Edick will be retiring from his day-to-day operational and chairman role after more than seven years with the company.
- The firm has appointed COO, John Shannon, as the new CEO and Marla Persky has been named chair, effective August 1.
- The company added it expects it Q2 total revenue to exceed $47 million, representing more than 23% growth over last year.
More on Xeris Pharmaceuticals
- Xeris Biopharma Holdings, Inc. (XERS) Q1 2024 Earnings Call Transcript
- Xeris stock jumps 14% on Phase 2 data for injected levothyroxine
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
